| Date | Title | Description | |
|---|---|---|---|
| 21 Oct 2021 | On business and financial situation | The Company informs of the delay in the decision on Risperidone ISM® by the U.S. Food and Drug Administration (“FDA”). | Download |
| 21 Oct 2021 | Liquidity and counterparty agreements | Download | |
| 07 Oct 2021 | Liquidity and counterparty agreements | Download | |
| 04 Oct 2021 | Liquidity and counterparty agreements | Download | |
| 01 Sep 2021 | On business and financial situation | ROVI informs about the joint statement from Moderna and Takeda on the investigation of suspended lots of the vaccine | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 28 Jul 2016 | Información sobre resultados (2) | ROVI releases the press release related to the 2016 first half results | Download |
| 28 Jul 2016 | Información sobre resultados | ROVI releases the presentation related to the 2016 first half results | Download |
| 05 Jul 2016 | Contratos de liquidez y contrapartida | Liquidity contract: transactions conducted in the second quarter of 2016 | Download |
| 24 Jun 2016 | Información sobre dividendos | The Company informs about the dividends payment | Download |
| 31 May 2016 | Convocatorias y acuerdos de Juntas y Asambleas generales | ROVI releases the information related to the agreements adopted by the 2016 General Shareholders Meeting | Download |